Latest filing published 14 Mar 2024 for PaxMedica, Inc., €381.
Karen LaRochelle appears in our data through filings on PaxMedica, Inc. shares, published by SEC (Form 4). In total, 13 filings cover trades dated from 2 March 2023 to 12 March 2024.
Every open-market trade on record is a sale: 8 sales worth €18k. Outside the open market, there are 5 share grants. In 2024 alone, the filings show no purchases and 1 sale.
The newest entry dates from 14 March 2024: a share grant of €381, in PaxMedica, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations